Benzinga's Top #PreMarket Losers By: Benzinga via Benzinga March 11, 2014 at 08:18 AM EDT Myriad Genetics (NASDAQ: MYGN) shares dropped 9.27% to $34.25 in pre-market trading after the US Court denied the company's motion to ... Read More >> Related Stocks: Arotech Corp Myriad Genetics Inc Oxford Lane Capital Urban Outfitters